<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0042">
 <label>42</label>
 <element-citation publication-type="journal" id="sbref0042">
  <person-group person-group-type="author">
   <name>
    <surname>Gray</surname>
    <given-names>GE</given-names>
   </name>
   <name>
    <surname>Moodie</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Metch</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Gilbert</surname>
    <given-names>PB</given-names>
   </name>
   <name>
    <surname>Bekker</surname>
    <given-names>LG</given-names>
   </name>
   <name>
    <surname>Churchyard</surname>
    <given-names>G</given-names>
   </name>
  </person-group>
  <article-title>Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study</article-title>
  <source>Lancet Infect Dis</source>
  <volume>14</volume>
  <year>2014</year>
  <fpage>388</fpage>
  <lpage>396</lpage>
  <pub-id pub-id-type="pmid">24560541</pub-id>
 </element-citation>
</ref>
